Literature DB >> 25206278

Impacts of common factors of life style on serum liver enzymes.

Joanna Danielsson1, Päivikki Kangastupa1, Tiina Laatikainen1, Mauri Aalto1, Onni Niemelä1.   

Abstract

AIM: To investigate the impacts of gender, age and factors of life style (alcohol, overweight, coffee and smoking) on serum liver enzymes.
METHODS: Serum alanine aminotransferase (ALT) and gamma-glutamyltransferase (GGT) were measured from 6269 apparently healthy individuals (2851 men, 3418 women, mean age 45 ± 12 years, range 25-74 years) in a national cross-sectional health survey. All subjects underwent detailed clinical examinations and interviews including the amount and pattern of alcohol use, coffee consumption and smoking habits.
RESULTS: In this population with a mean ± SD alcohol consumption of 65 ± 105 g/wk and body mass index (BMI) of 26.1 ± 4.3 kg/m(2), both ALT and GGT were significantly influenced by alcohol use (P < 0.001) and BMI (P < 0.001), whereas smoking increased only GGT (P < 0.001). A significant effect of age on ALT was seen in men (P < 0.001) whereas not in women. Significant two-factor interactions of alcohol use in men were observed with age (ALT: P < 0.01; GGT: P < 0.001) and BMI (GGT: P < 0.05). For ALT, a significant interaction also occurred between BMI and age (P < 0.005). In contrast, women showed significant interactions of alcohol use with BMI (GGT: P < 0.05), smoking (GGT: P < 0.001), and coffee consumption (GGT: P < 0.001).
CONCLUSION: Life-style associated changes in liver enzymes may reflect health risks, which should be considered in the definition of normal limits for liver enzymes.

Entities:  

Keywords:  Aging; Alcohol; Liver enzymes; Obesity; Oxidative stress; Smoking

Mesh:

Substances:

Year:  2014        PMID: 25206278      PMCID: PMC4155364          DOI: 10.3748/wjg.v20.i33.11743

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  53 in total

Review 1.  Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque.

Authors:  Michele Emdin; Alfonso Pompella; Aldo Paolicchi
Journal:  Circulation       Date:  2005-10-04       Impact factor: 29.690

2.  Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients.

Authors:  Giovanni Targher; Lorenzo Bertolini; Stefano Rodella; Roberto Tessari; Luciano Zenari; Giuseppe Lippi; Guido Arcaro
Journal:  Diabetes Care       Date:  2007-05-22       Impact factor: 19.112

3.  A strong secular trend in serum gamma-glutamyltransferase from 1996 to 2003 among South Korean men.

Authors:  Duk-Hee Lee; Myung-Hwa Ha; Sin Kam; Byungyeol Chun; Jangkyu Lee; Kyungeun Song; Yongchool Boo; Lyn Steffen; David R Jacobs
Journal:  Am J Epidemiol       Date:  2005-11-17       Impact factor: 4.897

4.  Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women.

Authors:  Duk-Hee Lee; Karri Silventoinen; Gang Hu; David R Jacobs; Pekka Jousilahti; Jouko Sundvall; Jaakko Tuomilehto
Journal:  Eur Heart J       Date:  2006-06-13       Impact factor: 29.983

5.  Alcohol dehydrogenase-1B genotype (rs1229984) is a strong determinant of the relationship between body weight and alcohol intake in Japanese alcoholic men.

Authors:  Akira Yokoyama; Tetsuji Yokoyama; Toshifumi Matsui; Takeshi Mizukami; Sachio Matsushita; Susumu Higuchi; Katsuya Maruyama
Journal:  Alcohol Clin Exp Res       Date:  2013-02-15       Impact factor: 3.455

6.  Age-related changes on serum ggt activity and the assessment of ethanol intake.

Authors:  Katri Puukka; Johanna Hietala; Heidi Koivisto; Petra Anttila; Risto Bloigu; Onni Niemelä
Journal:  Alcohol Alcohol       Date:  2006-07-19       Impact factor: 2.826

7.  Alcohol use, comorbidity, and mortality.

Authors:  Alison A Moore; Lisa Giuli; Robert Gould; Peifeng Hu; Kefei Zhou; David Reuben; Gail Greendale; Arun Karlamangla
Journal:  J Am Geriatr Soc       Date:  2006-05       Impact factor: 5.562

8.  Gamma glutamyltransferase and long-term survival: is it just the liver?

Authors:  Lili Kazemi-Shirazi; Georg Endler; Stefan Winkler; Thomas Schickbauer; Oswald Wagner; Claudia Marsik
Journal:  Clin Chem       Date:  2007-03-23       Impact factor: 8.327

9.  Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data.

Authors:  David A Leon; Jim McCambridge
Journal:  Lancet       Date:  2006-01-07       Impact factor: 79.321

10.  Serum aminotransferase activity and mortality risk in a United States community.

Authors:  Tae Hoon Lee; W Ray Kim; Joanne T Benson; Terry M Therneau; L Joseph Melton
Journal:  Hepatology       Date:  2008-03       Impact factor: 17.425

View more
  9 in total

1.  Ideal cardiovascular health and liver enzyme levels in European adolescents; the HELENA study.

Authors:  Idoia Labayen; Jonatan R Ruiz; Inge Huybrechts; Francisco B Ortega; Manuel Castillo; Michael Sjöstrom; Marcela González-Gross; Yannis Manios; Kurt Widhalm; Anthony Kafatos; Christina Breidenassel; Gerardo Rodríguez; Jean Dallongeville; Frédéric Gottrand; Luis A Moreno
Journal:  J Physiol Biochem       Date:  2017-01-06       Impact factor: 4.158

2.  Personality traits and facets linked with self-reported alcohol consumption and biomarkers of liver health.

Authors:  Martina Luchetti; Angelina R Sutin; Alessandro Delitala; Yannick Stephan; Edoardo Fiorillo; Michele Marongiu; Marco Masala; David Schlessinger; Antonio Terracciano
Journal:  Addict Behav       Date:  2018-03-06       Impact factor: 3.913

3.  Where should the safe limits of alcohol consumption stand in light of liver enzyme abnormalities in alcohol consumers?

Authors:  Onni Niemelä; Markus Niemelä; Risto Bloigu; Mauri Aalto; Tiina Laatikainen
Journal:  PLoS One       Date:  2017-12-05       Impact factor: 3.240

4.  Impacts of unfavourable lifestyle factors on biomarkers of liver function, inflammation and lipid status.

Authors:  Ulla Nivukoski; Markus Niemelä; Aini Bloigu; Risto Bloigu; Mauri Aalto; Tiina Laatikainen; Onni Niemelä
Journal:  PLoS One       Date:  2019-06-20       Impact factor: 3.240

5.  Data driven evaluation of healthy volunteer characteristics at screening for phase I clinical trials to inform on study design and optimize screening processes.

Authors:  Annemie Deiteren; Erwin Coenen; Sabine Lenders; Peter Verwilst; Erik Mannaert; Freya Rasschaert
Journal:  Clin Transl Sci       Date:  2021-08-11       Impact factor: 4.689

Review 6.  Biomarker-Based Approaches for Assessing Alcohol Use Disorders.

Authors:  Onni Niemelä
Journal:  Int J Environ Res Public Health       Date:  2016-01-27       Impact factor: 3.390

7.  Neglected features of lifestyle: Their relevance in non-alcoholic fatty liver disease.

Authors:  Francesca M Trovato; Giuseppe Fabio Martines; Daniela Brischetto; Guglielmo Trovato; Daniela Catalano
Journal:  World J Hepatol       Date:  2016-11-28

8.  Laboratory blood test results beyond normal ranges could not be attributed to healthy aging.

Authors:  Bozena Czarkowska-Paczek; Aleksandra Wyczalkowska-Tomasik; Leszek Paczek
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

9.  Combined effects of lifestyle risk factors on fatty liver index.

Authors:  Ulla Nivukoski; Markus Niemelä; Aini Bloigu; Risto Bloigu; Mauri Aalto; Tiina Laatikainen; Onni Niemelä
Journal:  BMC Gastroenterol       Date:  2020-04-15       Impact factor: 3.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.